Capital Research Global Investors Grifols Sa Transaction History

Capital Research Global Investors

$443 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$5.47 - $11.38 $19.4 Million - $40.3 Million	-3,537,532 Reduced 81.68%	793,690 $5.3 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $6,579 - $9,417	1,104 Added 0.03%	4,331,222 $36.8 Million
Q4 2021 Feb 14, 2022	SELL	$10.21 - $15.27 $584,216 - $873,749	-57,220 Reduced 1.3%	4,330,118 $48.6 Million
Q3 2021 Nov 15, 2021	SELL	$14.07 - $17.3 $47,050 - $57,851	-3,344 Reduced 0.08%	4,387,338 $64.1 Million
Q2 2021 Aug 16, 2021	BUY	$16.62 - $18.94 $66,330 - $75,589	3,991 Added 0.09%	4,390,682 $76.2 Million
Q1 2021 May 14, 2021	BUY	$15.15 - $19.78 $116,867 - $152,582	7,714 Added 0.18%	4,386,691 $75.8 Million
Q4 2020 Feb 12, 2021	BUY	$16.86 - $19.67 $230,172 - $268,534	13,652 Added 0.31%	4,378,977 $80.8 Million
Q3 2020 Nov 13, 2020	SELL	$15.4 - $20.16 $12,628 - $16,531	-820 Reduced 0.02%	4,365,325 $75.7 Million
Q2 2020 Aug 14, 2020	BUY	$18.24 - $21.45 $108,819 - $127,970	5,966 Added 0.14%	4,366,145 $79.7 Million
Q1 2020 May 15, 2020	BUY	$16.28 - $25.63 $123,646 - $194,659	7,595 Added 0.17%	4,360,179 $87.8 Million
Q4 2019 Feb 18, 2020	BUY	$19.57 - $23.52 $92,526 - $111,202	4,728 Added 0.11%	4,352,584 $101 Million
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $231,609 - $265,563	11,668 Added 0.27%	4,347,856 $87.1 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $17,590 - $21,100	1,000 Added 0.02%	4,336,188 $91.5 Million
Q4 2018 Feb 14, 2019	SELL	$17.44 - $21.53 $7.17 Million - $8.85 Million	-411,081 Reduced 8.66%	4,335,188 $79.6 Million
Q3 2018 Nov 14, 2018	SELL	$19.97 - $21.96 $7.62 Million - $8.38 Million	-381,799 Reduced 7.45%	4,746,269 $101 Million
Q2 2018 Aug 14, 2018	SELL	$20.16 - $24.68 $39.4 Million - $48.2 Million	-1,952,002 Reduced 27.57%	5,128,068 $110 Million
Q1 2018 May 15, 2018	SELL	$20.31 - $24.95 $63,042 - $77,444	-3,104 Reduced 0.04%	7,080,070 $150 Million
Q4 2017 Feb 14, 2018	SELL	$20.99 - $23.89 $17.2 Million - $19.5 Million	-817,169 Reduced 10.34%	7,083,174 $162 Million
Q3 2017 Nov 14, 2017	BUY	$20.07 - $21.89 $159 Million - $173 Million	7,900,343	7,900,343 $173 Million

Others Institutions Holding GRFS

# of Institutions

147

Shares Held

151M

Call Options Held

2.38M

Put Options Held

662K

Capital World Investors Los Angeles, CA

20.9M
Shares

$187 Million
0.02% of portfolio
Brandes Investment Partners, LP La Jolla, CA

18.6M
Shares

$166 Million
1.52% of portfolio
Permian Investment Partners, LP New York, NY

14.1M
Shares

$126 Million
11.06% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

13.9M
Shares

$124 Million
0.04% of portfolio
Black Creek Investment Management Inc. Toronto, A6

12.3M
Shares

$110 Million
2.9% of portfolio

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $6.06B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account